GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Addex Therapeutics Ltd (XSWX:ADXN) » Definitions » Days Sales Outstanding

Addex Therapeutics (XSWX:ADXN) Days Sales Outstanding : 87.67 (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Addex Therapeutics Days Sales Outstanding?

Addex Therapeutics's average Accounts Receivable for the three months ended in Dec. 2023 was CHF0.15 Mil. Addex Therapeutics's Revenue for the three months ended in Dec. 2023 was CHF0.15 Mil. Hence, Addex Therapeutics's Days Sales Outstanding for the three months ended in Dec. 2023 was 87.67.

The historical rank and industry rank for Addex Therapeutics's Days Sales Outstanding or its related term are showing as below:

XSWX:ADXN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 9.4   Med: 21.63   Max: 74.69
Current: 54.17

During the past 13 years, Addex Therapeutics's highest Days Sales Outstanding was 74.69. The lowest was 9.40. And the median was 21.63.

XSWX:ADXN's Days Sales Outstanding is ranked better than
65.85% of 893 companies
in the Biotechnology industry
Industry Median: 73.24 vs XSWX:ADXN: 54.17

Addex Therapeutics's Days Sales Outstanding increased from Dec. 2022 (55.10) to Dec. 2023 (87.67).


Addex Therapeutics Days Sales Outstanding Historical Data

The historical data trend for Addex Therapeutics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Addex Therapeutics Days Sales Outstanding Chart

Addex Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.83 9.40 14.58 74.69 59.63

Addex Therapeutics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 55.10 58.92 35.14 61.20 87.67

Competitive Comparison of Addex Therapeutics's Days Sales Outstanding

For the Biotechnology subindustry, Addex Therapeutics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Addex Therapeutics's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Addex Therapeutics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Addex Therapeutics's Days Sales Outstanding falls into.



Addex Therapeutics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Addex Therapeutics's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.417 + 0.11) / 2 ) / 1.613*365
=0.2635 / 1.613*365
=59.63

Addex Therapeutics's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.184 + 0.11) / 2 ) / 0.153*365 / 4
=0.147 / 0.153*365 / 4
=87.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Addex Therapeutics  (XSWX:ADXN) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Addex Therapeutics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Addex Therapeutics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Addex Therapeutics (XSWX:ADXN) Business Description

Traded in Other Exchanges
Address
Chemin des Aulx 12, Plan-les-Ouates, P.O. Box 68, Geneva, CHE, 1202
Addex Therapeutics Ltd is a biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe.

Addex Therapeutics (XSWX:ADXN) Headlines

From GuruFocus

Enamine Extend Collaboration With Prominent Swiss Biotech

By Business Wire Business Wire 02-24-2021